Clinical trial Recruiting at 5 sites Observational Ages 18 to 70

Exploring genetic factors in neuropathic pain

Official title: Exploring the Genetics of Neuropathic Pain

Run by Oslo University Hospital · NCT03862365 · Data updated 2026-11-12

This study is trying to find out if certain genes are linked to neuropathic pain to help understand why some people experience this condition.

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment5000 (estimated)
SponsorOslo University Hospital
Academic / other
Locations5 sites (Bergen and 4 other locations)
StatusRecruiting
StartedAugust 1, 2018
Main results expectedJanuary 1, 2027
Study endsDecember 31, 2027
Registry record updatedNovember 7, 2023
Trial IDNCT03862365 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 18 to 70 who have been referred for evaluation of possible distal symmetric polyneuropathy.

Probably not a fit

Patients who are too sick to participate or have conditions such as dementia or acute inflammatory polyneuropathy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify new genetic variants associated with the development of neuropathic pain, a condition affecting 7-8% of the general population. By utilizing existing population-based cohorts and establishing a registry and biobank for patients with neuropathy, the researchers will conduct genetic association studies to uncover molecular mechanisms underlying neuropathic pain. The study will involve international collaboration to ensure a large and diverse patient population, enhancing the reliability of the findings.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients suffering from neuropathic pain.

How similar studies have gone: Previous genetic studies on rare neuropathic disorders have shown promise in identifying mechanisms of neuropathic pain, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. The patient is between 18 and 70 years old.
2. The patient has consented.
3. The patient is referred for evaluation of possible distal symmetric polyneuropathy (DSPN).
4. The patient has filled out the questionnaires.

Exclusion Criteria:

1. The patient is too sick to participate (eg. bedridden, fever).
2. The patient is unable to consent (eg. dementia, speech problems, psychiatric disorder).
3. Inflammatory acute polyneuropathy.

Where it's running

  • Haukeland University Hospital
    Bergen, Norway
    Recruiting
  • Oslo University Hospital
    Oslo, Norway
    Recruiting
  • Helse Stavanger HF
    Stavanger, Norway
    Recruiting
  • University Hospital of North Norway
    Tromsø, Norway
    Recruiting
  • St. Olavs Hospital
    Trondheim, Norway
    Recruiting

Study contacts

  • Principal investigator: David Benett, M.D. — University of Oxford
  • Study coordinator: Kristian B. Nilsen, M.D
  • Email: uxnikq@ous-hf.no
  • Phone: +4791372241

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.